HALO logo
halo search icon
LB Pharmaceuticals, Inc.

US$28.00

Price Change Indicator
-0.03 (-0.107%)
LB Pharmaceuticals, Inc.
LBRX · NAS

LB Pharmaceuticals, Inc.

Start Trading LBRX for Free

US$28.00

Price Arrow-0.03 (-0.107%)
21/05/2026 04:00:01 PM
All-CompaniesAll-ConsensusBig CandleHALO AllHALO Earnings MomentumHammer BearishHammer Bearish (Realtime)Recent Earnings upgrade
Consensus Score
Lock Icon/10
Recommend
Lock
Target Price
Lock
Deviation
Lock
Unlock Full Consensus Insights

LB Pharmaceuticals, Inc. Overview

LBRX Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Neutral

HALO Model

Mqv

Very Weak

Garp

Very Weak

Mqv Small

Neutral

Valuation

Value

Lock Icon

Consensus

Lock Icon

Momentum

Price

Weak

Earnings

Very Strong

Growth

Earnings

Weak

Dividends

Very Weak

Quality

Capital Efficiency

Very Weak

Balance Sheet

Very Weak

About LBRX

icon

Website

LB Pharmaceuticals, Inc.

icon

Telephone

1.212.605.0300

icon

Address

Suite 1025, One Pennsylvania Plaza, New York, NY 10119

Description

LB Pharmaceuticals, Inc. engages in the research and development of novel therapies for the treatment of schizophrenia, bipolar depression, and other neuropsychiatric diseases. Its product pipeline includes LB-102, is a Phase 3-ready oral, small molecule for the treatment of acute schizophrenia, defined as a sudden and severe episode of psychotic symptoms, characterized by hallucinations, delusions, and other positive symptoms. The company was founded by Vince Grattan and Zachary Prensky in 2015 and is headquartered in New York.

LBRX Price Chart

Key Stats

Market Cap

US$803.81M

PE

0.00

EV/EBITDA

N/A

Dividends Overview

DIV Yield

0%

Franking

0%

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 13.36 - 33.47

Trade Value (12mth)

US$991,131.00

1 week

-5.5%

1 month

-11.8%

YTD

37.13%

1 year

0%

All time high

33.47

Key Fundamentals

EPS 3 yr Growth

55.80%

EBITDA Margin

0.00%

Operating Cashflow

-$35m

Free Cash Flow Return

-21.50%

ROIC

-15.40%

Interest Coverage

0.00

Quick Ratio

41.40

Other Data

Shares Outstanding (Fully Diluted)

28m

HALO Sector

Healthcare

Next Company Report Date

26-Mar-27

Next Ex Dividend Date

N/A

Next Dividend Pay Date

N/A

Reporting Currency

USD

Short Sell (% of issue)

0.00

LBRX Announcements

Latest Announcements

DateAnnouncements
14 May 26
14 May 26
13 May 26
13 May 26
13 May 26

LBRX Fundamentals

Per Share Records

Historical data

Forecast data

USD2021202220232024202320242025202620272028
Per Share, Growth & Valuations
EPS (Basic)
 $locklocklocklock-0.28-2.81-1locklocklock
EPS (Fully Diluted)
 $locklocklocklock-0.28-2.81-1locklocklock
Growth
 %locklocklocklock56.3-905.664.6locklocklock
PE
 XlocklocklocklockN/AN/AN/Alocklocklock
EV/EBITDA
 XlocklocklocklockN/AN/AN/Alocklocklock

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

0%

Franking Level

0%

DPSg

N/A

Quality Yield

lock

Falling Divs over next 2

lock

Want to learn more?Frequently asked questions.
What is the current share price of LB Pharmaceuticals, Inc. (LBRX:NAS)?
Halo FAQ
The current share price of LB Pharmaceuticals, Inc. (LBRX:NAS) is USD$28.00.
What is the 52-week high share price for LB Pharmaceuticals, Inc. (LBRX:NAS)?
Halo FAQ
The 52-week high share price for LB Pharmaceuticals, Inc. (LBRX:NAS) is USD$33.47.
What is the 52-week low share price for LB Pharmaceuticals, Inc. (LBRX:NAS)?
Halo FAQ
The 52-week low share price for LB Pharmaceuticals, Inc. (LBRX:NAS) is USD$13.36.
What is the dividend yield for LB Pharmaceuticals, Inc. (LBRX:NAS)?
Halo FAQ
LB Pharmaceuticals, Inc. (LBRX:NAS) does not pay a dividend.
What was LB Pharmaceuticals, Inc. (LBRX:NAS) last dividend payment?
Halo FAQ
LB Pharmaceuticals, Inc. (LBRX:NAS) does not pay a dividend.
What is the franking level for LB Pharmaceuticals, Inc. (LBRX:NAS)?
Halo FAQ
LB Pharmaceuticals, Inc. (LBRX:NAS) has a franking level of 0.00%.
In which sector is LB Pharmaceuticals, Inc. (LBRX:NAS) classified?
Halo FAQ
LB Pharmaceuticals, Inc. (LBRX:NAS) is classified in the Healthcare.

See beyond the curve.

One solution for research, investing and portfolio management.
Start FREE Trial